nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti-Inflammatory and Immunomodulatory Activities of Stem Cells
|
Peroni, John F. |
|
2011 |
27 |
2 |
p. 351-362 12 p. |
artikel |
2 |
Autologous Biologic Treatment for Equine Musculoskeletal Injuries: Platelet-Rich Plasma and IL-1 Receptor Antagonist Protein
|
Textor, Jamie |
|
2011 |
27 |
2 |
p. 275-298 24 p. |
artikel |
3 |
Cell-based Therapies: Current Issues and Future Directions
|
Stewart, Matthew C. |
|
2011 |
27 |
2 |
p. 393-399 7 p. |
artikel |
4 |
Cell-based Therapies for Equine Joint Disease
|
Frisbie, David D. |
|
2011 |
27 |
2 |
p. 335-349 15 p. |
artikel |
5 |
Cell-based Therapies for Tendon and Ligament Injuries
|
Alves, A.G.L. |
|
2011 |
27 |
2 |
p. 315-333 19 p. |
artikel |
6 |
Cell-based Therapies in Orthopedics
|
Stewart, Matthew C. |
|
2011 |
27 |
2 |
p. xiii-xiv nvt p. |
artikel |
7 |
Collection and Propagation Methods for Mesenchymal Stromal Cells
|
Taylor, Sarah E. |
|
2011 |
27 |
2 |
p. 263-274 12 p. |
artikel |
8 |
Commercial Cell-based Therapies for Musculoskeletal Injuries in Horses
|
Gutierrez-Nibeyro, Santiago D. |
|
2011 |
27 |
2 |
p. 363-371 9 p. |
artikel |
9 |
Contents
|
|
|
2011 |
27 |
2 |
p. vii-x nvt p. |
artikel |
10 |
Contributors
|
|
|
2011 |
27 |
2 |
p. iii-v nvt p. |
artikel |
11 |
Embryonic Stem Cells and iPS Cells: Sources and Characteristics
|
Hackett, Catherine H. |
|
2011 |
27 |
2 |
p. 233-242 10 p. |
artikel |
12 |
Evidence-Based Medicine and Stem Cell Therapy: How Do We Know Such Technologies are Safe and Efficacious?
|
Clegg, Peter D. |
|
2011 |
27 |
2 |
p. 373-382 10 p. |
artikel |
13 |
Forthcoming Issues
|
|
|
2011 |
27 |
2 |
p. xi- 1 p. |
artikel |
14 |
Index
|
|
|
2011 |
27 |
2 |
p. 401-409 9 p. |
artikel |
15 |
Mesenchymal Stem Cells: Characteristics, Sources, and Mechanisms of Action
|
Stewart, Matthew C. |
|
2011 |
27 |
2 |
p. 243-261 19 p. |
artikel |
16 |
Stem Cell–based Therapies for Bone Repair
|
Milner, Peter I. |
|
2011 |
27 |
2 |
p. 299-314 16 p. |
artikel |
17 |
The Regulation of Veterinary Regenerative Medicine and the Potential Impact of Such Regulation on Clinicians and Firms Commercializing These Treatments
|
Nobert Esq, Karl M. |
|
2011 |
27 |
2 |
p. 383-391 9 p. |
artikel |